Clinical efficacy of intramuscular human interferon‐βvs interferon‐α2b for the treatment of chronic hepatitis C

Journal of Viral Hepatitis

Volumn 2, Issue 2, 1995, Pages 103-106

  Perez R ^a   Pravia, R ^a   Artimez M L ^a   Giganto, F ^a   Rodriguez M ^a   Lombrana J L S ^a   Rodrigo, L ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

chronic hepatitis C; efficacy; hepatitis C virus; interferon ; interferon ; side effects

Indexed keywords

ALPHA2B INTERFERON; BETA INTERFERON;

ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS C; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

CHRONIC DISEASE; HEPATITIS C; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERFERON ALFA-2B; INTERFERON-BETA;

EID: 0029437224     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.1995.tb00014.x     Document Type: Article

References (8)

1. Interferon for non‐A, non‐B chronic hepatitis. A meta‐analysis of randomised clinical trials
2. Treatment of posttransfusion Non‐A, Non‐B acute and chronic hepatitis with human fibroblast β‐interferon: a preliminary report
3. Treatment of chronic non‐A non‐B hepatitis with human interferon β: a preliminary study
4. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
5. Resolution of acute hepatitis C after therapy with natural beta interferon
6. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon‐β
7. Alpha but not beta interferon (IFN) is useful in NA, NB chronic active hepatitis (CAH): Final report of a comparative, prospective, randomized study
8. Beta interferon treatment in chronic liver disease HCV related. Study of 86 patients